SHIMADA Masaru

J-GLOBAL         Last updated: May 10, 2018 at 19:07
 
Avatar
Name
SHIMADA Masaru
URL
http://www-user.yokohama-cu.ac.jp/~saikin/english/
Affiliation
Yokohama City University
Section
School of Medicine Medical Course , Microbiology Graduate School of Medicine Degree Program
Degree
Medical doctor(Yokohama City University)

Research Interests

 
 

Research Areas

 
 

Academic & Professional Experience

 
 
   
 
Associate Professor, Yokohama City University School of Medicine, Molecular Biodefennce Research, Medical Studies
 

Education

 
 
 - 
1997
Molecular Biology Immunology, Graduate School, Division of Medicine, Yokohama City University
 
 
 - 
1985
Faculty of Medicine, Nantong Medical College
 
 
 - 
1995
Medicine, Yokohama City University
 

Misc

 
Vaccine   32 5198-5205   Sep 2014
The gut-associated lymphoid tissue (GALT) represents a major reservoir of HIV in infected individuals. Vaccines can induce strong systemic immune responses but these have less impact on CD4 T cells activity and numbers in GALT. In this study, we v...
PLoS ONE   8    Mar 2013
We previously reported on a monoclonal antibody (mAb) that targeted amyloid beta (Aß) protein. Repeated injection of that mAb reduced the accumulation of Aß protein in the brain of human Aß transgenic mice (Tg2576). In the present study, cDNA enco...
PLoS ONE   7    Jan 2012
Adenovirus vector-based vaccine is a promising approach to protect HIV infection. However, a recent phase IIb clinical trial using the vector did not show its protective efficacy against HIV infection. To improve the vaccine, we explored the trans...
Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine.
SHIMADA Masaru
J. Immunol   15    2007

Research Grants & Projects

 
Viral vector-based vaccine development